Please enter verification code
Obstructive Sleep Apnoea: Another Burden on Cirrhotic Liver
Science Journal of Public Health
Volume 4, Issue 2-1, April 2016, Pages: 1-5
Received: Jul. 4, 2015; Accepted: Jul. 6, 2015; Published: Sep. 8, 2015
Views 4553      Downloads 159
Aliae AR Mohamed-Hussein, Chest Department, Assiut University Hospitals, Assiut, Egypt
Mohamed-Eltaher AA Ibrahim, Gastroenterology and Hepatology Department, Assiut University Hospitals, Assiut, Egypt
Article Tools
Follow on us
Obstructive sleep apnea syndrome (OSAS) may cause aggressive deterioration in the course of liver cirrhosis and may have an impact on the development of hepatic cell failure in patients with concomitant diseases. Patients and Methods: 34 patients with OSAS and compensated cirrhosis as well as 30 compensated cirrhotic patients were followed for 1 year to demonstrate the effect of hypoxia and body mass index (BMI) on their prognosis. Polysomnography, abdominal sonography, liver function tests and portal venous pressure were assessed on inclusion. Parameters of hepatic de-compensation (HD) as ascites, hepatic encephalopathy and bleeding esophageal varices (variceal hemorrhage) were recorded. Results: BMI was significantly higher in patients with concomitant OSAS and cirrhosis (p<0.01), and manifestations of hepatic de-compensation occurred in 32.3% of those cases compared to 10% in patients with cirrhosis alone (p<0.01) in one year. Positive correlations were recorded between BMI, desaturation index, sleep duration SpO2<90% and predictors of HD. Multivariate analysis showed that BMI, AHI, sleep duration SpO2< 90%, desaturation index were independent predictors of de-compensation, together with high portal venous pressure and lower serum albumin. Conclusion: Obesity and intermittent hypoxemia in OSAS may have deleterious effect on the natural history of compensated cirrhosis independent of portal venous pressure and liver function. Treatment of OSAS and weight reduction may decrease considerable burden on cirrhosis.
OSAS, Liver Cirrhosis, Ascites, Hepatic Encephalopathy, Variceal Hemorrhage, Obesity.
To cite this article
Aliae AR Mohamed-Hussein, Mohamed-Eltaher AA Ibrahim, Obstructive Sleep Apnoea: Another Burden on Cirrhotic Liver, Science Journal of Public Health. Special Issue: Obstructive Sleep Apnea: A Systemic Disease. Vol. 4, No. 2-1, 2016, pp. 1-5. doi: 10.11648/j.sjph.s.2016040201.11
El-Zayadi A, Selim O, Rafik M, etal., Prevalence of hepatitis C virus among non-A, non-B-related chronic liver disease in Egypt. J Hepatol. 1992; 14(2–3):416–417.
Mohamed-Hussein A AR and Wafy S. Prevalence and risk factors of obstructive sleep apnea syndrome in a population of upper Egypt, Eur Respir J 2010; 36: Suppl. 54, XXXs .
Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular diseases. J Am Coll Cardiol. 2008; 52: 686-717.
Levy P., Bonsignore M. R., Eckel J., Sleep, sleep-disordered breathing and metabolic consequences. Eur. Respir. J. 2009; 34: 243–260.
Drager L. F., Jun J. C., Polotsky V. Y., Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract. Res. Clin. Endocrinol. Metab. 2010; 24: 843–851.
Bonsignore M. R., Esquinas C., Barcelo A., et al., Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur. Respir. J. 2012; 39: 1136–1143.
Chin K, Nakamura T, Takahashi K, et al., Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med 2003; 114(5)370-376.
Norman D, Bardwell WA, Arosemena F, et al. Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep 2008; 31(1):121-126.
Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology.2007; 132:2087–2102. [PubMed: 17498505].
World Health Organization (WHO). Report of a WHO Consultation. Geneva: World Health Organization; 2000. Obesity: preventing and managing the global epidemic.
Matteoni CA, Younossi ZM, Gramlich T, et al., Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999; 116:1413– 1419. [PubMed: 10348825].
Ratziu V, Giral P, Charlotte F, et al. Liver fibrosis in overweight patients. Gastroenterology. 2000; 118:1117–1123. [PubMed: 10833486].
Ratziu V, Bonyhay L, Di M V, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 2002; 35:1485–1493. [PubMed: 12029634].
Naveau S, Giraud V, Borotto E, et al., Excess weight risk factor for alcoholic liver disease. Hepatology 1997; 25:108–111. [PubMed: 8985274].
Raynard B, Balian A, Fallik D, et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology. 2002; 35:635–638. [PubMed: 11870378].
Everhart JE, Lok AS, Kim HY, et al. Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology. 2009; 137:549–557. [PubMed: 19445938].
Berzigotti A. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis Hepatology. 2011 August; 54(2): 555–561.
El Awady ME, Hammouda K, Hassan A, et al., Insomnia and Obstructive Sleep Apnea among Egyptians: A Hospital-Based Study. Egyptian Journal of Neurology, Psychiatry & Neurosurgery2014; 51(1): 89.
Mohamoud Y, Mumtaz G, Riome S et al., The epidemiology of hepatitis C virus in Egypt: A systematic review and data synthesis. BMC Infectious Diseases 2013, 13:288.
Botros N, Concato J, Mohsenin V, et al., Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med. 2009; 122:1122–1127. [PMC free article] [PubMed]
Minoguchi K, Yokoe T, Tanaka A, et al., Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respir J. 2006; 28:378–385.
Everhart JE, Lok AS, Kim HY, et al. Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology. 2009; 137:549–557. [PubMed: 19445938].
Hosogai N, Fukuhara A, Oshima K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes2007; 56: 901–911.
Chen B, Lam KS, Wang Y, et al. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Commun2006; 341: 549–556.
Elmelegy NT, Mohamed-Hussein AAR. Serum Levels of Adiponectin, C - reactive protein and Tumor Necrosis Factor-alpha in Patients with Obstructive Sleep Apnea Syndrome: Effect of Nasal Continuous Positive Airway Pressure. Journal of Pulmonary &Respiratory Medicine2012; 1: 197.
Marra F, Bertolani C. Adipokines in liver diseases. Hepatology. 2009; 50:957–969. [PubMed: 19585655].
Aleffi S, Petrai I, Bertolani C, et al. Up regulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology. 2005; 42:1339–1348. [PubMed: 16317688].
Fernandez M, Semela D, Bruix J, et al., Angiogenesis in liver disease. J Hepatol. 2009; 50:604–620. [PubMed: 19157625].
BodenG, SheP, MozzoliM. Free fatty acids produce insulin resistance and activate the pro-inflammatory nuclear factor- kappa B pathway in liver. Diabetes 2005; 54: 3458–3465.
Cai,D., Yuan., Frantz,D.F., et al., Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF- kappa B. Nat .Med. 2005; 11: 183–190.
Drager LF, Li J, Reinke C, et al., Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity2011; 19: 2167–2174.
JunJC, DragerLF, NajjarSS, et al., Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. Sleep2011; 34: 1207–1213.
Novitskiy G, Potter JJ ,Wang L et al., Influences of reactive oxygen species and nitric oxide on hepatic fibrogenesis. Liver Int2006; 26: 1248–1257.
Ben-Neriah, Y., and Karin, M. Obesity is an independent risk factor for clinical decompensation in patients with Inflammation meets cancer, with NF-kappa B as the matchmaker. Nat. Immunol.2011; 12: 715–723.
Savransky V, Nanayakkara A, Vivero A, et al., Chronic Intermittent Hypoxia predispose to Liver Injury. Hepatology, 2007; 54(4): 1007-1013.
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186